PROJECT 2: TRANSLATIONAL REGULATION OF THE MEIOTIC CELL CYCLE IN THE MALE.

项目 2:男性减数分裂细胞周期的翻译调控。

基本信息

  • 批准号:
    8638813
  • 负责人:
  • 金额:
    $ 33.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-04-01 至 2016-03-31
  • 项目状态:
    已结题

项目摘要

Meiosis is the signature event of the germ cell developmental program, absolutely required for sexual reproduction eukaryotes. Proper regulation of meiotic progression is crucial for production of functional gametes. A key aspect of meiosis is a germ cell specific cell cycle, in which a final round of DNA synthesis (premeiotic S) is followed by a greatly extended G2, termed meiotic prophase, prior to the two meiotic divisions. This signature cell cycle delay provides critical time for homologous chromosomes to pair, synapse and recombine, as well as for major biosynthetic events that drive gamete differentiation. In oocytes, the transcriptional, translational and morphogenetic changes that produce the egg and prepare for early embryogenesis are largely accomplished during meiotic prophase. In male germ cells, although dramatic morphological changes that produce mature gametes occur after the meiotic divisions, a major part of the gene expression program that sets up spermiogenesis takes place during meiotic prophase. In both sexes, meiotic onset, progression, maturation, and activation of the meiotic divisions are key regulatory points. Understanding how these events are regulated is key for understanding the molecular basis of meiotic arrest infertility, for designing effective strategies for differentiating germ cells from embryonic precursors, and for developing and maturing competent gametes in vitro. The analysis proposed in this subproject of the U54 Cooperative Center for Reproductive and Stem Cell Biology will elucidate fundamental mechanisms that control the cell cycle for meiotic prophase, including the critical control circuits that first pause the cell cycle, then finally activate the G2/M transition for meiosis I once proper expression of the program for gametogenesis has been achieved.
减数分裂是生殖细胞发育计划的签名事件,绝对需要性爱 繁殖真核生物。对减数分裂进程的适当调节对于产生功能至关重要 配子。减数分裂的一个关键方面是生殖细胞特异性细胞周期,其中最后一轮DNA合成 (前s)随后是一个大大扩展的G2,称为减数分裂预言,在两个减数分裂之前 部门。此标志性细胞周期延迟为同源染色体配对,突触提供了关键的时间 和重组,以及驱动配子分化的重大生物合成事件。在卵母细胞中 转录,翻译和形态发生变化,产生卵并为早期做准备 在减数分裂预言期间,胚胎发生很大程度上是完成的。在男性生殖细胞中,虽然戏剧性 产生成熟配子的形态学变化发生在减数分裂师之后,这是基因的主要部分 建立精子发生的表达程序发生在减数分裂预言期间。在两个性别中,减数分裂 减数分裂分裂的发作,进展,成熟和激活是关键的调节点。理解 如何调节这些事件是理解减数分裂抑制不育症的分子基础的关键,因为 设计有效的策略,以区分生殖细胞和胚胎前体,以及开发和发展 在体外成熟胜任配子。 U54合作中心的这一副标理中提出的分析 对于生殖和干细胞生物学,将阐明控制细胞周期的基本机制 减数分裂预言,包括首先停止细胞周期的关键对照电路,然后最终激活 减数分裂的G2/M转变I曾经已经正确表达了该程序的配子发生。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARGARET T FULLER其他文献

MARGARET T FULLER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARGARET T FULLER', 18)}}的其他基金

Genetics and Developmental Biology Training Program
遗传学和发育生物学培训计划
  • 批准号:
    10630969
  • 财政年份:
    2022
  • 资助金额:
    $ 33.1万
  • 项目类别:
Genetics and Developmental Biology Training Program
遗传学和发育生物学培训计划
  • 批准号:
    10410329
  • 财政年份:
    2022
  • 资助金额:
    $ 33.1万
  • 项目类别:
Regulation of proliferation and differentiation in the male germ line adult stem cell lineage
雄性生殖系成体干细胞谱系增殖和分化的调节
  • 批准号:
    10417163
  • 财政年份:
    2020
  • 资助金额:
    $ 33.1万
  • 项目类别:
Regulation of proliferation and differentiation in the male germ line adult stem cell lineage
雄性生殖系成体干细胞谱系增殖和分化的调节
  • 批准号:
    10630243
  • 财政年份:
    2020
  • 资助金额:
    $ 33.1万
  • 项目类别:
Regulation of proliferation and differentiation in the male germ line adult stem cell lineage
雄性生殖系成体干细胞谱系增殖和分化的调节
  • 批准号:
    10449061
  • 财政年份:
    2020
  • 资助金额:
    $ 33.1万
  • 项目类别:
Regulation of proliferation and differentiation in the male germ line adult stem cell lineage
雄性生殖系成体干细胞谱系增殖和分化的调节
  • 批准号:
    10160936
  • 财政年份:
    2020
  • 资助金额:
    $ 33.1万
  • 项目类别:
Regulation of proliferation and differentiation in the male germ line adult stem cell lineage
雄性生殖系成体干细胞谱系增殖和分化的调节
  • 批准号:
    10675340
  • 财政年份:
    2020
  • 资助金额:
    $ 33.1万
  • 项目类别:
Regulation of proliferation and differentiation in the male germ line adult stem cell lineage
雄性生殖系成体干细胞谱系增殖和分化的调节
  • 批准号:
    10200518
  • 财政年份:
    2020
  • 资助金额:
    $ 33.1万
  • 项目类别:
Alternative polydenylation and the regulation of male germ cell differentiation
选择性多聚腺苷酸化和雄性生殖细胞分化的调节
  • 批准号:
    8822709
  • 财政年份:
    2014
  • 资助金额:
    $ 33.1万
  • 项目类别:
Alternative polydenylation and the regulation of male germ cell differentiation
选择性多聚腺苷酸化和雄性生殖细胞分化的调节
  • 批准号:
    8936332
  • 财政年份:
    2014
  • 资助金额:
    $ 33.1万
  • 项目类别:

相似海外基金

Pathogenesis of thrombotic microangiopathies
血栓性微血管病的发病机制
  • 批准号:
    10608740
  • 财政年份:
    2023
  • 资助金额:
    $ 33.1万
  • 项目类别:
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma
了解淋巴瘤对蛋白精氨酸甲基转移酶抑制剂的耐药机制
  • 批准号:
    10668754
  • 财政年份:
    2023
  • 资助金额:
    $ 33.1万
  • 项目类别:
Restriction of KSHV by cellular RNA decay pathways
细胞 RNA 衰变途径对 KSHV 的限制
  • 批准号:
    10699800
  • 财政年份:
    2023
  • 资助金额:
    $ 33.1万
  • 项目类别:
A Novel Long Noncoding RNA Associated with Systemic Lupus Erythematosus Pathogenesis
一种与系统性红斑狼疮发病机制相关的新型长非编码RNA
  • 批准号:
    10725130
  • 财政年份:
    2022
  • 资助金额:
    $ 33.1万
  • 项目类别:
MicroRNA Mouse Models and Alzheimer’s Disease
MicroRNA 小鼠模型和阿尔茨海默病
  • 批准号:
    10526166
  • 财政年份:
    2022
  • 资助金额:
    $ 33.1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了